Mr David Tamblyn

• Journals

  Year	Citation
  2022	Husereau, D., Drummond, M., Augustovski, F., de Bekker-Grob, E., Briggs, A. H., Carswell, C., . . . Molsen, E. (2022). Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations. European Journal of Health Economics, 23(8), 1309-1317. DOI Scopus9 Europe PMC3
  2015	Leach, D. A., Need, E. F., Toivanen, R., Trotta, A. P., Palenthorpe, H. M., Tamblyn, D. J., . . . Buchanan, G. (2015). Erratum: Stromal androgen receptor regulates the composition of the microenvironment to influence prostate cancer outcome [Oncotarget. 2015; 6:16135-16150]. Oncotarget, 6(34), 36923. DOI Scopus3 WoS2 Europe PMC2
  2015	Leach, D., Need, E., Toivanen, R., Trotta, A., Palenthorpe, H., Tamblyn, D., . . . Buchanan, G. (2015). Stromal androgen receptor regulates the composition of the microenvironment to influence prostate cancer outcome. Oncotarget, 6(18), 16135-16150. DOI Scopus62 WoS55 Europe PMC47
  2014	Merlin, T., Tamblyn, D., Ellery, B., & NAHTA Quality Assurance Group. (2014). What's in a name? developing definitions for common health technology assessment product types of the international network of agencies for health technology assessment (Inahta). International Journal of Technology Assessment in Health Care, 30(4), 430-437. DOI Scopus28 WoS27 Europe PMC17
  2011	Tamblyn, D., Chopra, S., Yu, C., Kattan, M., Pinnock, C., & Kopsaftis, T. (2011). Comparative analysis of three risk assessment tools in Australian patients with prostate cancer. BJU International, 108(Suppl 2), 51-57. DOI Scopus18 WoS17 Europe PMC9
  2009	Beckmann, K., Pinnock, C., Tamblyn, D., Kopsaftis, T., Stapleton, A., & Roder, D. (2009). Clinical and socio-demographic profile of an Australian multi-institutional prostate cancer cohort. Asia Pacific Journal of Clinical Oncology, 2009(5), 247-256. DOI Scopus11 WoS10
  2008	Stapleton, A., Johns, R., Kopsaftis, T., & Tamblyn, D. (2008). Abnormal PSA tests: delays in referral. Australian Family Physician, 37(1-2), 84-88. Scopus8 WoS8 Europe PMC2

• Books

  Year	Citation
  2011	Doidge, J., Merlin, T., Liufu, Z., Tamblyn, D., Jia, L., & Hiller, J. (2011). Review of Interim Funded Service: Vertebroplasty and New Review of Kyphoplasty. Australia: Commonwealth of Australia.
  2011	Tamblyn, D., Ellery, B., & Merlin, T. (2011). Review of Interim Funded Service: Brachytherapy for the Treatment of Prostate Cancer: assessment report. Australia: Commonwealth of Australia.

• Conference Papers

  Year	Citation
  2009	Beckmann, K., Pinnock, C. B., Tamblyn, D. J., Kopsaftis, T., Stapleton, A. M. F., & Roder, D. (2009). Prostate cancer in South Australia: equitable access but later presentation. In BJU INTERNATIONAL Vol. 103 (pp. 11-12). Gold Coast, AUSTRALIA: WILEY-BLACKWELL PUBLISHING, INC.

• Conference Items

  Year	Citation
  2015	Vogan, A., Mitchell, A., Tamblyn, D., & Merlin, T. (2015). Managed Entry Schemes: Enabling Access To Oncology Drugs Under Uncertainty. Poster session presented at the meeting of the 12th Annual Health Technology Assessment international (HTAi) Conference. Oslo, Norway.
  2013	Moshi, M. R., Tamblyn, D., & Merlin, T. (2013). Rise of Co-dependent Technologies: Surveying Stakeholders’ about their opinion on the co-dependent technology framework and decision-making process [Poster]. Poster session presented at the meeting of SA State Population Health Conference. Adelaide, South Australia.
  2013	Merlin, T. L., Ellery, B., Juneja, V., & Tamblyn, D. (2013). What’s in a name? - Mapping the different HTA products of INAHTA members. Poster session presented at the meeting of the 10th Annual Meeting Health Technology Assessment international (HTAi). Seoul, South Korea.

• Report for External Bodies

  Year	Citation
  2022	Milverton, J., Demir, M., Carter, D., Hill, H., Parsons, J., Tamblyn, D., & Vogan, A. (2022). Genetic testing for children with hearing impairment (MSAC Application 1680). Canberra: Commonwealth of Australia.
  2022	Kessels, S., Mittal, R., Newton, S., & Tamblyn, D. (2022). Review of different minimally invasive therapeutic approaches for the management of patients with benign prostatic hyperplasia (MSAC FFP review 1697). Canberra: Commonwealth of Australia.
  2020	Tamblyn, D., Vogan, A., Parsons, J., Schubert, C., Bellman, S., & Carter, D. (2020). Technical report to supplement clinical utility card for genetic testing for diagnosis of inheritable cardiomyopathies (MSAC Application 1599). Canberra: Commonwealth of Australia.
  2020	Tamblyn, D., Vogan, A., Parsons, J., Schubert, C., Bellman, S., & Carter, D. (2020). Clinical utility card for heritable cardiomyopathies.
  2016	Tamblyn, D., Schubert, C., & Merlin, T. L. (2016). Guidelines for preparing a submission to the Pharmaceutical Benefits Advisory Committee, Version 5.0. Commonwealth of Australia.
  2012	Morona, J. K., Newton, S., Wang, S., Tamblyn, D., Ellery, B., & Merlin, T. (2012). Genetic testing for hereditary mutations in the VHL gene that cause von Hippel-Lindau syndrome (MSAC Application number 1153,). Canberra, ACT.: Commonwealth of Australia.

• NHMRC Endorsed Guidelines

  Year	Citation
  2015	Title: National Evidence-Based Guideline on Secondary Prevention of Cardiovascular Disease in Type 2 Diabetes Authors: Morona J, Tamblyn D, Ellery B, Merlin T Author affiliation: A1007279-A1050252-A1068278-A1018746 Publisher: Commonwealth of Australia - Department of Health Place of publication: Australia Publication date: 2015 ISBN-13: 9780980604092 Source URL: http://t2dgr.bakeridi.edu.au/LinkClick.aspx?fileticket=H_EpLXHAX_s=&tabid=172 Verification-status: Verified Record created at source: 15 April 2016
  2011	Publication status: Published Title: National evidence-based guideline: Prevention, identification and mangement of foot complications in diabetes Authors: Fitridge R, Templeton S, Buckley E, Docter S, Morona J, Reddin E, Juneja V, Merlin T Author affiliation: A1066006-A1066294-B1134193-B1181052-B1007279-B1200662-B1216790-B1050252-B1183605-B1068278-B1177181-B1018746 Pagination: 0 pages Publication date: 2011 Language: en Notes: Migrated record 20140814 Verification-status: Verified Record created at source: 14 August 2014

Mr Tamblyn has taught into the University of Adelaide bachelor of medicine and surgery, and into both undergraduate and post-graduate public health. Topics covered include health economics, evaluation methods and epidemiology.

• Consulting/Advisories

  Date	Institution	Department	Organisation Type	Country
  2021 - ongoing	South Australian Medicines Evaluation Panel (SAMEP)	SA Health	Health services and related	Australia
  2018 - 2023	National Health and Medical Research Council	National Health and Medical Research Council	Health services and related	Australia
  2018 - ongoing	South Australian Policy Advisory Committee on Technology (SAPACT)	SA Health	Health services and related	Australia
  2018 - ongoing	TGA Expert Advisory Panel, Breast Implant Associated ALCL	Therapeutics Goods Administration	Health services and related	Australia
  2017 - ongoing	International Journal for Technology Assessment in Health Care	Editors	Scientific research	United Kingdom

• Presentation

  Date	Topic	Presented at	Institution	Country
  2017 - 2017	Pharmaceutical Benefits Advisory Committee (PBAC) Guidelines Evaluator Workshop	Canberra	AHTA, presenting at request of Australian Government Department of Health	Australia
  2016 - 2016	Pharmaceutical Benefits Advisory Committee (PBAC) Guidelines Review Submission Sponsor Workshop	Sydney (3), Melbourne (2)	AHTA, presenting at request of Australian Government Department of Health	Australia

• Position: AHTA Manager
• Phone: 83130608
• Email: david.tamblyn@adelaide.edu.au
• Campus: North Terrace
• Building: 44-60 Rundle Mall - Rundle Mall Plaza, floor Level Four
• Org Unit: Adelaide Health Technology Assessment